Viromed Medical AG
4.96
EUR
+0.12
(+2.48%)
ISIN
DE000A40ZVN7
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Semi-annual Revenue
EUR
•
in mil. unless spec.Semi-annual Earnings Per Share
EUR
•
in mil. unless spec.Semi-annual Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- CEO
- Uwe Perbandt
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Rellingen Germany
- Website
- fonterelli.de
- Similar Companies
- Business
- Viromed Medical AG is a Germany-based medical technology company that develops, manufactures, and commercializes innovative medical equipment, therapeutic devices, and infection control solutions based on cold atmospheric plasma technology. The company operates across various healthcare and clinical sectors, specializing in wound healing, dermatology, intensive care medicine, podiatry, veterinary care, and air purification. Its core product and service portfolio comprises cold atmospheric plasma medical devices, including the ViroCAP mobile device series for the contactless, medication-free treatment of acute and chronic wounds, infected skin lesions, and multi-resistant bacterial pathogens; dedicated application models comprising ViroCAP derma for clinical dermatological applications, ViroCAP podo for professional foot and nail treatments, and ViroCAP VET for veterinary indications; the PulmoPlas cold plasma inhalation therapy system, developed for the clinical prevention and treatment of ventilator-associated pneumonia and respiratory bacterial infections in mechanically ventilated intensive care patients; clean room and environmental decontamination equipment, including mobile plasma air purifiers such as the KLINIK AKUT V 500 system for inactivating aerosol-bound viruses, bacteria, and spores; and complementary consumer healthcare formulations encompassing nutritional supplements, medical cosmetics, and health products. The company serves public and private hospitals, intensive care facilities, outpatient clinics, medical practices, nursing homes, and pharmacies across domestic and international markets. Originally rooted in operational activities established in 2004 and structured under its current corporate entity in 2021 before undergoing a reverse business combination and rebranding in 2022, Viromed Medical AG is headquartered in Rellingen, Germany. In recent major corporate and operational developments, the company has executed strategic vertical integration and commercial expansion measures, including initiating the acquisition of relyon plasma GmbH from TDK Electronics AG to internalize research, development, and serial manufacturing for its plasma technology platforms; completing the integration of pharmedix GmbH to expand into broader medical and nutritional segments; securing an exclusive multi-country European OEM distribution alliance with HELLMUT RUCK GmbH for podiatry devices; entering into an exclusive DACH veterinary distribution agreement with Lang Life Sciences GmbH; and establishing international distribution partnerships extending its commercial reach across Turkey with TriPart TITAN GmbH & Co. KG, as well as Spain, Portugal, Greece, the Balkan region, Romania, and Saudi Arabia.